Maciej Krzakowski

Maciej Krzakowski

UNVERIFIED PROFILE

Are you Maciej Krzakowski?   Register this Author

Register author
Maciej Krzakowski

Maciej Krzakowski

Publications by authors named "Maciej Krzakowski"

Are you Maciej Krzakowski?   Register this Author

81Publications

3176Reads

15Profile Views

Solitary fibrous tumour along with non-small-cell lung cancer and Doege-Potter syndrome.

Kardiochir Torakochirurgia Pol 2019 Mar 4;16(1):49-51. Epub 2019 Apr 4.

Department of Lung Cancer and Chest Tumours, Maria Skłodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5114/kitp.2019.83948DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491374PMC
March 2019

First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer.

N Engl J Med 2018 12 25;379(23):2220-2229. Epub 2018 Sep 25.

From Vanderbilt University Medical Center (L. Horn) and Sarah Cannon Research Institute-Tennessee Oncology (M.L.J.), Nashville; Mayo Clinic, Rochester, MN (A.S.M.); Mazowieckie Centrum Leczenia Chorób Płuc i Gruźlicy, Otwock (A. Szczęsna), and Centrum Onkologii-Instytut im. Marii Skłodowskiej-Curie w Warszawie, Warsaw (M.K.) - both in Poland; Thomayerova Nemocnice, Pneumologická Klinika 1.LF UK, Prague, Czech Republic (L. Havel); the Department of Respiratory and Critical Care Medicine (M.J.H.) and the 2nd Department of Respiratory and Critical Care Medicine (F.H.), Ludwig Boltzmann Institute for COPD and Respiratory Epidemiology-Sozialmedizinisches Zentrum Baumgartner Höhe, Otto-Wagner-Spital, Vienna; Semmelweis Egyetem ÁOK, Pulmonológiai Klinika, Budapest, Hungary (G.L.); the Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo (M.N.); LungenClinic Grosshansdorf, Airway Research Center North, German Center for Lung Research, Grosshansdorf, Germany (M.R.); State Key Laboratory of South China, Chinese University of Hong Kong, Hong Kong (T.M.), and F. Hoffmann-La Roche, Shanghai (J.L.) - both in China; Genentech, South San Francisco, CA (S.L., D.S.S., B.D., A.L.-C., F.K., W.L., A. Sandler); and Georgetown University, Washington DC (S.V.L.).

View Article

Download full-text PDF

Source
http://www.nejm.org/doi/10.1056/NEJMoa1809064
Publisher Site
http://dx.doi.org/10.1056/NEJMoa1809064DOI Listing
December 2018

Efficacy and Safety of Nintedanib Plus Docetaxel in Patients with Advanced Lung Adenocarcinoma: Complementary and Exploratory Analyses of the Phase III LUME-Lung 1 Study.

Target Oncol 2017 08;12(4):475-485

Department of Thoracic Oncology, LungenClinic Grosshansdorf, Airway Research Center North (ARCN), Member of the German Center for Lung Research (DZL), 22927, Grosshansdorf, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11523-017-0517-2DOI Listing
August 2017

A decrease in D-dimer concentration and an occurrence of skin rash as iatrogenic events and complementary predictors of survival in lung cancer patients treated with EGFR tyrosine kinase inhibitors.

Pharmacol Rep 2016 Dec 20;68(6):1140-1148. Epub 2016 Jul 20.

Department of Pulmonary Circulation and Thromboembolic Diseases, Centre of Postgraduate Medical Education, European Health Centre Otwock, Otwock, Poland. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pharep.2016.07.003DOI Listing
December 2016

Cyclophosphamide and tucotuzumab (huKS-IL2) following first-line chemotherapy in responding patients with extensive-disease small-cell lung cancer.

Anticancer Drugs 2015 Nov;26(10):1061-8

aChelyabinsk Regional Clinical Oncology Dispensary, Chelyabinsk, Russia bDepartment and Clinic of Oncology, Poznan University of Medical Sciences, Poznan cDepartment of Chemotherapy, Alfred Sokolowski Specialized Hospital, Szczecin dDepartment of Pulmonology, Oncology and Allergology, Medical University of Lublin, Lublin eDepartment of Pulmonary Diseases, Lower Silesian Center for Pulmonary Diseases, Wroclaw fDepartment of Lung and Chest Cancers, Maria Sklodowska-Curie Institute of Oncology, Warsaw, Poland gEMD Serono Inc., GEDU - Oncology, Rockland, Massachusetts, USA hMerck Serono Research and Development, Institute of Drug Metabolism and Pharmacokinetics, Grafing, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CAD.0000000000000281DOI Listing
November 2015

Correlation between TS, MTHFR, and ERCC1 gene polymorphisms and the efficacy of platinum in combination with pemetrexed first-line chemotherapy in mesothelioma patients.

Clin Lung Cancer 2014 Nov 15;15(6):455-65. Epub 2014 Aug 15.

Department of Pneumonology, Oncology and Allergology, Medical University of Lublin, Lublin, Poland; Institute of Agricultural Medicine of Lublin, Lublin, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2014.06.009DOI Listing
November 2014

EGFR mutation testing on cytological and histological samples in non-small cell lung cancer: a Polish, single institution study and systematic review of European incidence.

Int J Clin Exp Pathol 2013 15;6(12):2800-12. Epub 2013 Nov 15.

Department of Diagnostic Hematology, Institute of Hematology and Transfusion Medicine Warsaw ; Department of Pathology, Maria Skłodowska-Curie Memorial Cancer Centre and Institute of Oncology Warsaw.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3843260PMC
August 2014

Randomized, phase III trial of first-line figitumumab in combination with paclitaxel and carboplatin versus paclitaxel and carboplatin alone in patients with advanced non-small-cell lung cancer.

J Clin Oncol 2014 Jul 2;32(19):2059-66. Epub 2014 Jun 2.

Corey J. Langer, University of Pennsylvania; Anthony J. Olszanski, Fox Chase Cancer Center, Philadelphia, PA; Daniel D. Karp, MD Anderson Center, Houston, TX; Rebecca J. Benner, Judith R. Scranton, Pfizer Oncology, Groton, CT; Silvia Novello, University of Turin, Orbassano, Italy; Keunchil Park, Sungkyunkwan University School of Medicine, Seoul, Korea; Maciej Krzakowski, The Maria Sklodowska-Curie Institute of Oncology, Warsaw; Jacek Jassem, Medical University of Gdansk, Gdansk, Poland; Tony Mok, Chinese University, Hong Kong, Special Administrative Region, People's Republic of China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.54.4932DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4067944PMC
July 2014

Randomized phase II trial of Onartuzumab in combination with erlotinib in patients with advanced non-small-cell lung cancer.

J Clin Oncol 2013 Nov 7;31(32):4105-14. Epub 2013 Oct 7.

David R. Spigel, Thomas J. Ervin, and Davey B. Daniel, Sarah Cannon Research Institute; David R. Spigel, Tennessee Oncology, Nashville; Davey B. Daniel, Chattanooga Oncology Hematology Associates, Chattanooga, TN; Thomas J. Ervin, Florida Cancer Specialists, Fort Myers; Michael S. Wertheim, Hematology/Oncology Associates, Port St Lucie, FL; Rodryg A. Ramlau, Poznan University of Medical Sciences, Poznan; Maciej J. Krzakowski, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland; Jerome H. Goldschmidt Jr, Blue Ridge Cancer Care, Christianburg, VA; George R. Blumenschein Jr, The University of Texas MD Anderson Cancer Center, Houston, TX; Gilles Robinet, University Hospital Morvan, Brest; Benoit Godbert, Centre Hospitalier Universitaire Nancy, Vandoeuvre-lès-Nancy; Fabrice Barlesi, Assistance Publique-Hôpitaux de Marseille, Aix Marseille University, Marseille, France; Ramaswamy Govindan, Washington University School of Medicine, St Louis, MO; Taral Patel, Mid Ohio Oncology/Hematology, Columbus, OH; Sergey V. Orlov, St Petersburg Pavlov State Medical University, St Petersburg, Russia; Wei Yu, Robert L. Yauch, Premal H. Patel, and See-Chun Phan, Genentech; Amy C. Peterson, Medivation, San Francisco, CA; and Jiping Zha, Crown Bioscience, Taicang City, China.

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/early/2013/10/07/JCO.2012.47
Web Search
http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2012.47.4189
Publisher Site
http://dx.doi.org/10.1200/JCO.2012.47.4189DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4878106PMC
November 2013

Prognostic value of synaptophysin and chromogranin a expression in patients receiving palliative chemotherapy for advanced non-small-cell lung cancer.

Respiration 2013 3;85(4):289-96. Epub 2012 Apr 3.

Department of Lung Cancer and Chest Tumors, Maria Skłodowska-Curie Memorial Cancer Center and Institute, Warsaw, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000337090DOI Listing
October 2013

Erlotinib in salvage treatment of patients with advanced non-small cell lung cancer: results of an expanded access programme in Poland.

Contemp Oncol (Pozn) 2012 29;16(2):170-5. Epub 2012 May 29.

The Maria Sklodowska-Curie Memorial Cancer Centre and Institute, Department of Lung Cancer and Chest Tumours, Warsaw, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5114/wo.2012.28798DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3687401PMC
June 2013

Crizotinib in the treatment of non-small-cell lung carcinoma.

Contemp Oncol (Pozn) 2012 4;16(6):480-4. Epub 2013 Jan 4.

Lung Cancer Department, Maria Sklodowska-Curie Memorial Cancer Centre and Institute of Oncology, Warsaw, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5114/wo.2012.32477DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3687470PMC
June 2013

[Gefitinib in patients with advanced non-small-cell lung cancer].

Pneumonol Alergol Pol 2012 ;80(5):439-49

Klinika Nowotworów Płuca i Klatki Piersiowej, Centrum Onkologii--Instytut, ul. Roentgena 5,02–781 Warszawa.

View Article

Download full-text PDF

Source
February 2013

The qualification of docetaxel or erlotinib for second-line therapy should be based on clinical and molecular predictive factors.

Chemotherapy 2012 16;58(1):60-9. Epub 2012 Feb 16.

Department of Pneumonology, Oncology and Allergology, Medical University of Lublin, Lublin, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000336143DOI Listing
July 2012

The applicability of a predictive index for second- and third-line treatment of unselected non-small-cell lung cancer patients.

Respiration 2011 18;82(4):341-50. Epub 2011 Jan 18.

Department of Pneumonology, Oncology and Allergology, Medical University, Lublin, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000322843DOI Listing
January 2012

CTLA-4, CD28, and ICOS gene polymorphism associations with non-small-cell lung cancer.

Hum Immunol 2011 Oct 24;72(10):947-54. Epub 2011 May 24.

Department of Experimental Therapy, Institute of Immunology and Experimental Therapy, Polish Academy of Science, Wroclaw, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.humimm.2011.05.010DOI Listing
October 2011

[Diagnosis and treatment of thyroid cancer - Polish guidelines].

Endokrynol Pol 2010 Sep-Oct;61(5):518-68

Polskie Towarzystwo Endokrynologiczne.

View Article

Download full-text PDF

Source
August 2011

[Recommendations on systemic treatment of non-small cell lung cancer and maligant pleural mesothelioma].

Pneumonol Alergol Pol 2010 ;78(6):384-5

Centrum Onkologii - Instytut im. M. Skłodowskiej-Curie, Klinika Nowotworów Płuca i Klatki Piersiowej w Warszawia.

View Article

Download full-text PDF

Source
December 2010

Effects of megestrol acetate in patients with cancer anorexia-cachexia syndrome--a systematic review and meta-analysis.

Pol Arch Med Wewn 2008 Nov;118(11):636-44

Department of Internal Medicine, Jagiellonian University Medical College, Kraków, Poland.

View Article

Download full-text PDF

Source
http://www.pamw.kei.pl/sites/default/files/lesniak_en_full.p
Web Search
November 2008

[Pancreatic endocrine tumors - management guidelines (recommended by the Polish Network of Neuroendocrine Tumors)].

Endokrynol Pol 2008 Jan-Feb;59(1):68-86

Klinka Endokrynologii Katedra Patofizjologii i Endokrynologii, Slaski Uniwersytet Medyczny, Zabrze, Poland.

View Article

Download full-text PDF

Source
June 2008

Anemia profiles in patients with lung cancer: what have we learned from the European Cancer Anaemia Survey (ECAS)?

Lung Cancer 2005 Dec 26;50(3):401-12. Epub 2005 Sep 26.

Medical Oncology Department, Hygeia Hospital, 2 An. Tsoha & Vasilissis Sofias Street, Athens 11521, Greece.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2005.08.004DOI Listing
December 2005

Systemic therapy options in malignant bone diseases.

Ortop Traumatol Rehabil 2005 Oct;7(5):567-72

Centrum Onkologii-Instytut im. Marii Skłodowskiej-Curie, Warszawa.

View Article

Download full-text PDF

Source
October 2005

[Brain metabolic disorders after chemotherapy in the study by magnetic resonance spectroscopy].

Neurol Neurochir Pol 2003 ;37(4):783-98

Zakładu Medycyny Nuklearnej i Rezonansu Magnetycznego Wojewódzkiego Szpitala Bródnowskiego w Warszawie.

View Article

Download full-text PDF

Source
March 2004

Bone metastases: the current state of knowledge and the prospects for pharmacological treatment.

Ortop Traumatol Rehabil 2003 Apr;5(2):219-22

Centrum Onkologii, Instytut im. Marii Skłodowskiej-Curie, Warszawa.

View Article

Download full-text PDF

Source
April 2003

Cancer clinical trials in Central and Eastern Europe: historical review.

Crit Rev Oncol Hematol 2002 May;42(2):157-61

Deptartment of Oncology and Radiotherapy, Medical University of Gdańsk, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s1040-8428(01)00170-6DOI Listing
May 2002